Paul N. Mortenson

2.5k citations

22 papers · 1.6k indexed · 1 hit paper · h-index 18

Molecular Biology top 10%
Computational Theory and Mathematics top 0.5%
Materials Chemistry
Organic Chemistry top 5%
Pharmacology top 10%

Co-authors: Christopher W. Murray Marcel L. Verdonk Michael J. Hartshorn Richard J. Hall David J. Wales Gianni Chessari Suzanne Brewerton Wijnand T. M. Mooij
Topics: Computational Drug Discovery Methods (11 papers)Protein Structure and Dynamics (9 papers)Spectroscopy and Quantum Chemical Studies (3 papers)
Cited by: Computational Theory and Mathematics Molecular Biology Organic Chemistry
Journals: Journal of Biological Chemistry The Journal of Chemical Physics Physical review. B, Condensed matter
Partner nations: United Kingdom Switzerland Netherlands

In The Last Decade

Paul N. Mortenson

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance

2007 501 citations Michael J. Hartshorn, Marcel L. Verdonk et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Paul N. Mortenson

Since Specialization

Citations

This map shows the geographic impact of Paul N. Mortenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul N. Mortenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul N. Mortenson more than expected).

Fields of papers citing papers by Paul N. Mortenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul N. Mortenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul N. Mortenson. The network helps show where Paul N. Mortenson may publish in the future.

Co-authorship network of co-authors of Paul N. Mortenson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul N. Mortenson. A scholar is included among the top collaborators of Paul N. Mortenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul N. Mortenson. Paul N. Mortenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Does a Machine-Learned Potential Perform Better Than an Optimally Tuned Traditional Force Field? A Case Study on Fluorohydrins 2023 ·Journal of Chemical Information and Modeling ·(unknown),Paul N. Mortenson,J. Willem M. Nissink,Jonathan W. Essex,Chris‐Kriton Skylaris	7
2	ParaMol: A Package for Automatic Parameterization of Molecular Mechanics Force Fields 2021 ·Journal of Chemical Information and Modeling ·(unknown),Paul N. Mortenson,Marcel L. Verdonk,Richard A. Ward,Jonathan W. Essex,Chris‐Kriton Skylaris	26
3	C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD) 2021 ·Chemical Science ·Gianni Chessari,Rachel Grainger,(unknown),R. Frederick Ludlow,Paul N. Mortenson,David C. Rees	20
4	Generation of Quantum Configurational Ensembles Using Approximate Potentials 2021 ·Journal of Chemical Theory and Computation ·(unknown),Paul N. Mortenson,J. Willem M. Nissink,Marcel L. Verdonk,Richard A. Ward,Jonathan W. Essex,Chris‐Kriton Skylaris	2
5	Fragment-to-Lead Medicinal Chemistry Publications in 2019 2020 ·Journal of Medicinal Chemistry ·Wolfgang Jahnke,Daniel A. Erlanson,Iwan J. P. de Esch,Christopher N. Johnson,Paul N. Mortenson,(unknown),(unknown)	49
6	Fragment-to-Lead Medicinal Chemistry Publications in 2017 2018 ·Journal of Medicinal Chemistry ·Paul N. Mortenson,Daniel A. Erlanson,Iwan J. P. de Esch,Wolfgang Jahnke,Christopher N. Johnson	48
7	Predicting “Hot” and “Warm” Spots for Fragment Binding 2017 ·Journal of Medicinal Chemistry ·Prakash Chandra Rathi,R. Frederick Ludlow,Richard J. Hall,Christopher W. Murray,Paul N. Mortenson,Marcel L. Verdonk	26
8	Fragment-to-Lead Medicinal Chemistry Publications in 2016 2017 ·Journal of Medicinal Chemistry ·Christopher N. Johnson,Daniel A. Erlanson,Wolfgang Jahnke,Paul N. Mortenson,David C. Rees	42
9	Efficient exploration of chemical space by fragment-based screening 2014 ·Progress in Biophysics and Molecular Biology ·Richard J. Hall,Paul N. Mortenson,Christopher W. Murray	112
10	Fragment-Based Approaches to the Discovery of Kinase Inhibitors 2014 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Paul N. Mortenson,Valério Berdini,Marc O’Reilly	14
11	Allosteric Inhibition of the Neuropeptidase Neurolysin 2014 ·Journal of Biological Chemistry ·Christina S. Hines,Kallol Ray,(unknown),Fei Xiong,(unknown),Mia L. Pras‐Raves,(unknown),Jos H.M. Lange,Manana Melikishvili,Michael G. Fried,Paul N. Mortenson,M. Charlton,Yogendra Patel,Stephen M. Courtney,Chris G. Kruse,David W. Rodgers	17
12	Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase 2013 ·ACS Medicinal Chemistry Letters ·Steven Howard,Nader Amin,Andrew B. Benowitz,Elisabetta Chiarparin,Haifeng Cui,(unknown),Tom D. Heightman,David Holmes,(unknown),Jianzhong Huang,Qi Jin,Constantine Kreatsoulas,Agnés C. L. Martin,(unknown),Lynn McCloskey,Paul N. Mortenson,Puja Pathuri,Dominic Tisi,Pamela A. Williams	20
13	Assessing the lipophilicity of fragments and early hits 2011 ·Journal of Computer-Aided Molecular Design ·Paul N. Mortenson,Christopher W. Murray	83
14	Docking Performance of Fragments and Druglike Compounds 2011 ·Journal of Medicinal Chemistry ·Marcel L. Verdonk,Ilenia Giangreco,Richard J. Hall,Oliver Korb,Paul N. Mortenson,Christopher W. Murray	100
15	Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor 2010 ·Journal of Medicinal Chemistry ·David Moffat,Sanjay R. Patel,(unknown),Andrew Belfield,Alastair Donald,Martin Rowlands,Judata I. Wibawa,Deborah H. Brotherton,Lindsay Stimson,Vanessa Clark,(unknown),Lindsay J. Bawden,Gary Box,Elisabeth A. Bone,Paul N. Mortenson,Anthea Hardcastle,(unknown),Suzanne A. Eccles,Florence I. Raynaud,Wynne Aherne	67
16	Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening 2008 ·Bioorganic & Medicinal Chemistry Letters ·João Neres,Mark L. Brewer,(unknown),Horacio Botti,Alejandro Buschiazzo,Philip N. Edwards,Paul N. Mortenson,M. Charlton,Pedro M. Alzari,Alberto C.C. Frasch,Richard A. Bryce,Kenneth T. Douglas	56
17	Protein−Ligand Docking against Non-Native Protein Conformers 2008 ·Journal of Chemical Information and Modeling ·Marcel L. Verdonk,Paul N. Mortenson,Richard J. Hall,Michael J. Hartshorn,Christopher W. Murray	109
18	Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performancebreakdown → 2007 ·Journal of Medicinal Chemistry ·Michael J. Hartshorn,Marcel L. Verdonk,Gianni Chessari,Suzanne Brewerton,Wijnand T. M. Mooij,Paul N. Mortenson,Christopher W. Murray	501
19	Energy landscapes of model polyalanines 2002 ·The Journal of Chemical Physics ·Paul N. Mortenson,David A. Evans,David J. Wales	70
20	Crystals of binary Lennard-Jones solids 2001 ·Physical review. B, Condensed matter ·(unknown),J. Hernández‐Rojas,Paul N. Mortenson,David J. Wales	71

About Paul N. Mortenson

Paul N. Mortenson is a scholar working on Computational Theory and Mathematics, Pharmaceutical Science and Pharmacology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (11 papers), Protein Structure and Dynamics (9 papers) and Spectroscopy and Quantum Chemical Studies (3 papers). The work is most often cited by research in Computational Theory and Mathematics (763 citations), Molecular Biology (1.1k citations) and Organic Chemistry (327 citations). Paul N. Mortenson has collaborated with scholars based in United Kingdom, Switzerland and Netherlands. Frequent co-authors include Christopher W. Murray, Marcel L. Verdonk, Michael J. Hartshorn, Richard J. Hall, David J. Wales, Gianni Chessari, Suzanne Brewerton, Wijnand T. M. Mooij, Christopher N. Johnson and Daniel A. Erlanson. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Chemical Physics and Physical review. B, Condensed matter.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact